Poster preliminary proof-of-concept studies

Poster preliminary proof-of-concept studies

Barcelona – 2A Pharma presents poster at the World Vaccine Congress Europe During the World Vaccine Congress Europe, we presented more details about our preliminary proof-of-concept studies and the development of the active vaccine against EpCAM+ cancers, which...